Avoid injecting directly over visible veins
Bufalin inhibits hTERT expression and colorectal cancer cell growth by targeting CPSF4
We will begin testing his blood more often
References: (1) Huang T, Zhang K, Sun L, Xue X, Zhang C, Shu Z, Mu N, Gu J, Zhang W, Wang Y, Zhang Y, Zhang W
Who is at Risk for Deficiency : Women who menstruate and/or are postpartum may be at increased risk due to blood loss
Key dosing points from the study: Dose range: 200500 mcg per session (individual variation based on severity and body weight) Frequency: 23 sessions per week during the active treatment phase Duration: 48 weeks of active treatment Route: Local subcutaneous injection proximal to the affected joint Concurrent therapy: Most patients continued physical therapy alongside BPC-157 treatment The combination of local administration and physical therapy aligns with the hypothesis that BPC-157 accelerates structural repair while functional loading (exercise) guides proper tissue remodeling